This content is from: Portfolio Stock Buyback ROI Edges into the Black, Barely Buybacks eked out a small gain in the second quarter, but too many companies are still sitting on repurchased shares that have tumbled in value. By S.L. Mintz October 04, 2016
This content is from: Portfolio Last Year Private Equity Couldn’t Get Enough Healthcare. Now Deals Have Dried Up. Higher supply costs and investors laying low after a rough first quarter are among the drivers. By Jessica Hamlin April 26, 2022
This content is from: Research Stock Buybacks Wrestle with an Aging Bull Apple forges ahead with its massive share repurchases, but most companies must ponder how long this market will last and how it will affect their buyback ROI. By S.L. Mintz March 27, 2015
This content is from: Portfolio The Risk in No-Risk Stock Buybacks Many companies are now struggling with falling stock shares: Do they use buybacks to placate shareholders even at the risk of making a lousy investment? By S.L. Mintz April 18, 2016
This content is from: Portfolio Have Stock Buybacks Lost Their Credibility? In a volatile market, many companies struggle to justify large share-repurchase programs, according to our latest Corporate Buyback Scorecard. By S.L. Mintz June 27, 2016
This content is from: Corner Office Stock Buybacks Prepare for the Bear Market Share repurchases posted lower returns for the sixth successive quarter, provoking new criticism. And now the task gets more challenging. By S.L. Mintz October 09, 2015
